These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pulmonary manifestations of polymyositis/dermatomyositis. Hallowell RW; Ascherman DP; Danoff SK Semin Respir Crit Care Med; 2014 Apr; 35(2):239-48. PubMed ID: 24668538 [TBL] [Abstract][Full Text] [Related]
5. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders. Emmi L; Chiarini F Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582 [TBL] [Abstract][Full Text] [Related]
6. Assessment of Mortality in Autoimmune Myositis With and Without Associated Interstitial Lung Disease. Johnson C; Pinal-Fernandez I; Parikh R; Paik J; Albayda J; Mammen AL; Christopher-Stine L; Danoff S Lung; 2016 Oct; 194(5):733-7. PubMed ID: 27166633 [TBL] [Abstract][Full Text] [Related]
7. Management of Interstitial Lung Disease in Patients With Myositis Specific Autoantibodies. Mecoli CA; Christopher-Stine L Curr Rheumatol Rep; 2018 Apr; 20(5):27. PubMed ID: 29637383 [TBL] [Abstract][Full Text] [Related]
8. Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. Sharma N; Putman MS; Vij R; Strek ME; Dua A J Rheumatol; 2017 Nov; 44(11):1612-1618. PubMed ID: 28864644 [TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitors in a cohort of patients with antisynthetase-associated interstitial lung disease. Labirua-Iturburu A; Selva-O'Callaghan A; Martínez-Gómez X; Trallero-Araguás E; Labrador-Horrillo M; Vilardell-Tarrés M Clin Exp Rheumatol; 2013; 31(3):436-9. PubMed ID: 23465087 [TBL] [Abstract][Full Text] [Related]
12. Serologic and clinical response to treatment of systemic vasculitis and associated autoimmune disease with intravenous immunoglobulin. Levy Y; Sherer Y; George J; Langevitz P; Ahmed A; Bar-Dayan Y; Fabbrizzi F; Terryberry J; Peter J; Shoenfeld Y Int Arch Allergy Immunol; 1999 Jul; 119(3):231-8. PubMed ID: 10436395 [TBL] [Abstract][Full Text] [Related]
13. Remarkable benefits of intravenous immunoglobulin (IVIG) in a patient with polymyositis-associated acute interstitial lung disease. Peshbahar S; Bendstrup E Eur Clin Respir J; 2020 Oct; 7(1):1840706. PubMed ID: 33224454 [TBL] [Abstract][Full Text] [Related]
14. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies. Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004 [TBL] [Abstract][Full Text] [Related]
15. [Mechanisms of immunoglobulins activity]. Kowalczyk D Pol Merkur Lekarski; 2011 Jun; 30(180):397-9. PubMed ID: 21751546 [TBL] [Abstract][Full Text] [Related]